Aethlon Medical Inc
Change company Symbol lookup
Select an option...
AEMD Aethlon Medical Inc
HRVSF Harvest Health & Recreation Inc
UA Under Armour Inc
TRWH Twin River Worldwide Holdings Inc
F Ford Motor Co
JKHY Jack Henry & Associates Inc
JNJ Johnson & Johnson
HMN Horace Mann Educators Corp
KOSS Koss Corp
FNF Fidelity National Financial Inc

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.


Last Trade
0.045 (3.45%)
B/A Size

Market Hours

Closing Price
Day's Change
-0.005 (-0.38%)
Bid close
Ask close
B/A Size
Day's High
Day's Low
(Above Average)

10-day average volume:

UPDATE: 20 stocks that investors hate but Wall Street loves as the S&P 500 nears a record high

4:22 pm ET August 8, 2020 (MarketWatch)

By Philip van Doorn, MarketWatch

The rally for U.S. stocks from the March bottom has been remarkable, but most S&P 500 stocks are down for 2020

This has been an adventurous year for stocks, with almost a full rebound for the S&P 500 Index from the pandemic lows of late March. But the rally has not been as broad as you might think.

Below is a list of 20 stocks that are still down at least 20% for 2020, but also have majority "buy" or equivalent ratings among sell-side analysts.

The FAANG-led recovery

Ben Carlson said a lot with a tweet Wednesday morning:


This turnaround has been fueled by the tremendous increase in the money supply resulting from the timely action of the Federal Reserve and the federal government. Very low interest rates play their part. The yield on 10-year U.S. Treasury notes is 0.55%, while the dividend yield for the entire S&P 500 Index is 1.70%, according to FactSet.

The S&P 500 was up 3.5% (with dividends reinvested) for 2020 through Aug. 4.

But the S&P 500 is weighted by market capitalization and therefore dominated by the FAANG stocks, to which we add Microsoft Corp. (MSFT):

Company Ticker Total return - 2020 Share of S&P 500 market cap

Facebook, Inc. Class A US:FB 22% 2.2%

Apple Inc. US:AAPL 50% 6.9%, Inc. US:AMZN 70% 5.7%

Netflix Inc. US:NFLX 58% 0.8%

Alphabet Inc. Class C US:GOOG 10% 1.8%

Alphabet Inc. Class A US:GOOGL 10% 1.6%

Microsoft Corp. US:MSFT 36% 5.9%

Source: FactSet

Together, the FAANG group plus Microsoft make up 25% of the S&P 500. Their outperformance this year has had a great effect on the entire index's return.

Loved by Wall Street

Among the S&P 500, 292 stocks that were down for 2020 (with dividends reinvested) through Aug. 4. That may be a big surprise and it underscores the influence of the big tech names listed above.

Among those 292 stocks, 149 were down at least 20%.

Here are the 20 stocks among the S&P 500 down at least 20% this year that have the highest percentage "buy" or equivalent ratings among sell-side analysts polled by FactSet. The table is sorted by the percentage of "buy" ratings. (Scroll to the right to see all the data.):

Company Ticker Industry Total return - 2020 through Aug. 4 Share 'buy' ratings Closing price - Aug. 4 Cons. price target Implied 12-month upside potential

Phillips 66 US:PSX Oil Refining/Marketing -43% 95% $61.85 $82.11 33%

Pioneer Natural Resources Co. US:PXD Oil & Gas Production -33% 92% $99.52 $121.46 22%

Diamondback Energy Inc. US:FANG Oil & Gas Production -55% 91% $41.07 $58.00 41%

AES Corp. US:AES Electric Utilities -20% 90% $15.47 $17.75 15%

ConocoPhillips US:COP Oil & Gas Production -41% 89% $37.64 $50.08 33%

Valero Energy Corp. US:VLO Oil Refining/Marketing -41% 86% $53.02 $71.79 35%

Concho Resources Inc. US:CXO Oil & Gas Production -41% 86% $51.47 $72.66 41%

Citigroup Inc. US:C Financial Conglomerates -35% 85% $50.14 $69.38 38%

Las Vegas Sands Corp. US:LVS Casinos/Gaming -35% 84% $43.73 $58.47 34%

General Motors Co. US:GM Motor Vehicles -29% 84% $25.80 $38.44 49%

Baker Hughes Co. Class A US:BKR Oilfield Services/Equipment -36% 83% $16.19 $20.56 27%

Hartford Financial Services Group Inc. US:HIG Multi-Line Insurance -32% 78% $40.57 $51.56 27%

Citizens Financial Group Inc. US:CFG Regional Banks -38% 76% $24.21 $29.28 21%

TechnipFMC PLC US:FTI Oilfield Services/Equipment -61% 75% $8.26 $11.34 37%

Marathon Petroleum Corp. US:MPC Oil Refining/Marketing -36% 75% $37.69 $47.79 27%

Ross Stores Inc. US:ROST Apparel/Footwear Retail -24% 74% $88.38 $104.83 19%

Capital One Financial Corp. US:COF Major Banks -38% 74% $63.24 $80.08 27%

Synchrony Financial US:SYF Finance/Rental/Leasing -35% 74% $22.65 $28.36 25%

Raytheon Technologies Corp. US:RTX Aerospace & Defense -34% 74% $57.51 $77.56 35%

Wynn Resorts Ltd. US:WYNN Casinos/Gaming -47% 72% $72.75 $97.56 34%

Source: FactSet

Don't miss:This $20 billion bond fund produced outsized returns by capitalizing on market turmoil, and is set to do it again (

-Philip van Doorn; 415-439-6400;

(END) Dow Jones Newswires

August 08, 2020 16:22 ET (20:22 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.